- Home
- MNSB vs ARCT Comparison
MNSB vs ARCT Comparison
Compare MNSB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | ARCT |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | 171 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.9M | 193.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MNSB | ARCT |
|---|---|---|
| Price | $24.39 | $6.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | 50.9K | ★ 389.6K |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | $1.50 | N/A |
| Revenue Next Year | $3.77 | $12.77 |
| P/E Ratio | $12.64 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.86 | $5.85 |
| 52 Week High | $25.19 | $24.14 |
Technical Indicators
Market Signals| Indicator | MNSB | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.14 | 38.75 |
| Support Level | $22.00 | $6.71 |
| Resistance Level | $25.17 | $7.93 |
| Average True Range (ATR) | 0.67 | 0.39 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 66.37 | 4.20 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.